Azenta, Inc. (FRA:BA3)
Germany
· Delayed Price · Currency is EUR | Market Cap | 1.39B |
| Revenue (ttm) | 506.11M |
| Net Income (ttm) | -47.53M |
| Shares Out | n/a |
| EPS (ttm) | -1.04 |
| PE Ratio | n/a |
| Forward PE | 44.27 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Average Volume | 12 |
| Open | 30.00 |
| Previous Close | 29.80 |
| Day's Range | 29.60 - 30.00 |
| 52-Week Range | 21.80 - 52.50 |
| Beta | n/a |
| RSI | 58.44 |
| Earnings Date | Nov 21, 2025 |
About Azenta
Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences market in the United States, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates through three reportable segments: Sample Management Solutions, Multiomics, and B Medical Systems. The Sample Management Solutions segment provides sample management products and solutions, including automated stores, cryogenic systems, automated sample tubes, consumables and instruments,... [Read more]
Financial Performance
In 2025, Azenta's revenue was $593.82 million, a decrease of -9.52% compared to the previous year's $656.32 million. Losses were -$59.50 million, -63.76% less than in 2024.
Financial numbers in USD Financial StatementsNews
Raymond James Raises Price Target on Azenta (AZTA) to $45 | AZTA Stock News
Raymond James Raises Price Target on Azenta (AZTA) to $45 | AZTA Stock News
Azenta, Inc. 2025 Q4 - Results - Earnings Call Presentation
2025-11-22. The following slide deck was published by Azenta, Inc.
Azenta Inc (AZTA) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
Azenta Inc (AZTA) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Positioning Amid Challenges
Q4 2025 Azenta Inc Earnings Call Transcript
Q4 2025 Azenta Inc Earnings Call Transcript
Azenta outlines 3%–5% organic revenue growth and 300 bps margin expansion for 2026 amid operational overhaul
Azenta, Inc. (AZTA) Q4 2025 Earnings Call Transcript
AZTA Crosses Above Key Moving Average Level
In trading on Friday, shares of Azenta Inc (Symbol: AZTA) crossed above their 200 day moving average of $32.09, changing hands as high as $34.00 per share. Azenta Inc shares are currently trading up a...
Ross Stores Posts Strong Q3 Results, Joins Enviri, Azenta And Other Big Stocks Moving Higher On Friday
U.S. stocks were mixed, with the Dow Jones gaining around 150 points on Friday. Shares of Ross Stores Inc (NASDAQ: ROST) rose sharply during Friday's session after the company reported better-than-ex...
Azenta (AZTA) Surpasses Q4 Expectations with Strong Revenue Growth
Azenta (AZTA) Surpasses Q4 Expectations with Strong Revenue Growth
Azenta (AZTA) Surpasses Revenue Expectations for Q4
Azenta (AZTA) Surpasses Revenue Expectations for Q4
Azenta (AZTA) Projects Significant EBITDA Margin Growth by 2025
Azenta (AZTA) Projects Significant EBITDA Margin Growth by 2025
Azenta Non-GAAP EPS of $0.21 beats by $0.01, revenue of $159M beats by $2.64M; gives FY26 outlook
Azenta Reports Fourth Quarter and Full Year Fiscal 2025 Results, Ended September 30, 2025
Q4'25 reported revenue growth of 6% year over year and 4% on an organic basis FY'25 reported revenue growth of 4% and 3% on an organic basis FY'25 Adjusted EBITDA margin expansion of 310 basis points ...
Pre-Market Earnings Report for November 21, 2025 : BJ, AZTA, MOG.A
The following companies are expected to report earnings prior to market open on 11/21/2025. Visit our Earnings Calendar for a full list of expected earnings releases.BJ's Wholesale Club Holdings, Inc....
Azenta FQ4 2025 Earnings Preview
Get the latest on Azenta (AZTA) FQ4 earnings with estimates and performance trends. Discover what to watch before market open.
Earnings Outlook For Azenta
Azenta (NASDAQ: AZTA) will release its quarterly earnings report on Friday, 2025-11-21. Here's a brief overview for investors ahead of the announcement. Analysts anticipate Azenta to report an earnin...
Azenta Announces Fiscal 2025 Fourth Quarter and Full Year Conference Call and Webcast
BURLINGTON, Mass. , Nov. 12, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal fourth quarter and full year 2025 earnings which ended on September 30, 2025, on Friday, November 21,...
Azenta Life Sciences Partners with PRECEDE Foundation to Advance Early Detection of Pancreatic Cancer
BURLINGTON, Mass. , Nov. 4, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced a strategic partnership with the PRECEDE Foundation, an international, multi-institutional collaborative fo...
Azenta (AZTA) Receives Analyst Upgrade and Price Target Increase | AZTA Stock News
Azenta (AZTA) Receives Analyst Upgrade and Price Target Increase | AZTA Stock News
Azenta to Host Investor Day at its Biorepository Facility in Indianapolis, Indiana
BURLINGTON, Mass. , Oct. 15, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that it will host an Investor Day on Wednesday, December 10, 2025, at the Company's biorepository facility...
Azenta, Inc. (AZTA) Q3 2025 Earnings Call Transcript
Azenta, Inc. (NASDAQ:AZTA) Q3 2025 Earnings Conference Call August 6, 2025 8:30 AM ET Company Participants John P. Marotta - President, CEO & Director Lawrence Y.
Azenta Reports Third Quarter Results for Fiscal 2025, Ended June 30, 2025; Reiterates Full Year Fiscal 2025 Guidance
BURLINGTON, Mass. , Aug. 5, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today reported financial results for the third quarter ended June 30, 2025.
Azenta Life Sciences Partners with Frenova, a Division of Fresenius Medical Care, and Nephronomics to Advance Genomic Research in Nephrology
BURLINGTON, Mass. , July 31, 2025 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that it has entered a collaboration with Frenova, a division of Fresenius Medical Care, and Nephronomics, ...
Fresenius Medical Care's Third-Party Clinical Research Organization Frenova Announces Strategic Collaboration Advancing Genomics-Driven, Precision Kidney Disease Care
Frenova and Nephronomics, a renal precision company co-founded by Fresenius Medical Care, initiate collaboration with GENEWIZ by Azenta Life Sciences Provides vital insights through sophisticated geno...